Long-term PPI use · testing

Long-Term PPI Use: What Your Blood Work and Body Can Show

Long-term PPI use shows up first in blood work: two or more years on the pill carried 1.65 times the odds of vitamin B12 deficiency, rising to 1.95 on higher doses, with minerals pointing the same way. Bioimpedance body composition adds the belly fat behind reflux pressure.

Years on an acid pill can quietly change what your body absorbs, and the rebound when you stop is real. Neither shows up at a routine visit unless someone decides to measure.

Long-term PPI use usually begins as a short course that nobody ends. A proton pump inhibitor such as omeprazole is started for a few weeks, and years later no one has checked what a stomach held near neutral has changed elsewhere. The video The Heartburn Pill You Can’t Quit, from The Angry Gut by Dr. Gurpreet Singh Padda, MD, MBA, MHP, and Ami Michelle Grimes, makes the full case about the drug. The angle here is measurement: what the pill can change in your own numbers, what a routine visit leaves unchecked, and which of those changes a test can actually show.

The correction: low acid does not cause reflux

For years I repeated an elegant idea to patients. Reflux happens because the stomach makes too little acid, and without enough acid the valve at the top of the stomach never gets the signal to close. It was tested in people, and it failed. Heartburn patients took omeprazole twice a day for a week while a sensor counted every upward splash, acidic or not. The number of reflux events did not go down. Only their chemistry changed, with the acid portion falling from 45% to 3%.

The real trigger is mechanical. When 84 people in three weight categories were compared, their valves had similar pressure and length, yet the brief relaxations that let acid escape ran 2.1, 3.8 and 7.3 times an hour, climbing with body weight. The pressure difference across the junction rose with it, from 4.5 to 10.0 mm Hg. Reflux is plumbing under pressure, and much of that pressure comes from the belly.

Why the heartburn comes back harder when you stop

Hold stomach acid down for weeks and the hormone gastrin rises. The cells that answer gastrin multiply, so the acid-making machinery is quietly expanded while it sits switched off. Remove the pill and that extra capacity turns on at once. This is rebound acid hypersecretion, and it is not proof that your original problem is still there.

Two randomized trials tested it in healthy volunteers who had never had reflux. After eight weeks on a proton pump inhibitor, 44% developed clinically relevant acid symptoms in the month after stopping, against 15% on placebo. A second trial with a different drug again found 44%, against 9% on placebo. The flare typically begins somewhere between day 5 and day 14 and settles within a few days for most people, although measured oversecretion can persist beyond 8 weeks.

The system around the prescription does the rest. A refill costs a click. Asking whether the drug still has a job takes a visit nobody schedules. Some people genuinely need acid suppression: after a bleeding ulcer, with erosive esophagitis or Barrett’s esophagus, or while taking an anti-inflammatory every day. Whether you are one of them is a decision for the physician who prescribed it, never a reason to stop on your own.

Stomach acid is measured elsewhere

Measura [Cardiometabolic and Autonomic Health Analysis] does not test stomach acid. Gastric pH monitoring, impedance studies, acid output measurement and endoscopy are gastroenterology tests done in other settings, and so is testing for H. pylori. Those tests decide whether reflux is real and whether a stomach truly under-produces acid.

Truly low acid exists, but it is uncommon. Among 248 volunteers aged 65 and over, 84% had acidic stomach contents at rest, and only about 11% consistently made too little. The two main causes are autoimmune gastritis, which destroys the cells that secrete acid, and long-standing H. pylori infection that thins the lining. Symptoms cannot pick those people out, which is why the answer comes from a test your physician orders. The stomach-lining side is covered in atrophic gastritis and B12 absorption. What Measura can measure is the body the acid was protecting.

Does long-term PPI use lower B12 and minerals?

Acid is the step that loosens vitamin B12 from the food protein carrying it. In one large analysis, two or more years on a proton pump inhibitor carried an odds ratio of 1.65 for B12 deficiency, against 1.25 for the weaker H2 blocker class, and the figure climbed to 1.95 in people taking more than 1.5 pills a day. A risk that grows with the dose is hard to dismiss as coincidence.

Minerals point the same way with less certainty. In kidney transplant recipients, low magnesium carried an odds ratio of 2.16, and in renal transplant recipients iron deficiency ran at 1.57, rising to 2.30 on a high dose. Those are narrow, medically complex groups, and their numbers are not your personal odds.

Laboratory panels are how that part of the picture becomes a number instead of a guess. Which markers a panel includes is your physician’s call, and years on an acid suppressor is exactly the history that makes B12 and minerals worth raising. A single result has limits, explained in what a test result can and cannot tell you.

How does a PPI change protein digestion, and why does belly fat matter?

Pepsin, the stomach enzyme that starts breaking down protein, works only in acid. With the pH raised, protein leaves the stomach largely intact and arrives at a small intestine that expected it already opened. The gut is the first brain, and it runs on what it can take apart, not on what sits on the plate.

The other half is fat around the middle. Of the lifestyle measures tested against reflux in a systematic review, only weight loss and raising the head of the bed held up, and both work on pressure. Abdominal fat is also active tissue that feeds metaflammation, the low-grade inflammation that keeps a metabolism irritated, and it has an upstream cause in a food supply that subsidizes acellular carbohydrates. Bioimpedance body composition separates fat mass from lean mass, so weight loss can be tracked as fat lost rather than muscle lost. Why that matters more than weight is explained in body composition, not BMI.

Do PPIs cause dementia, fractures or kidney disease?

Long-term PPI use side effects make frightening headlines. In a three-year trial of 17,598 people assigned at random to pantoprazole or a dummy pill, pneumonia, fractures, kidney disease and dementia were all tracked. Only enteric infection differed, at 1.4% against 1.0%. A dementia hazard ratio of 1.44 from observational data did not reproduce, and reviewers grade most of the fracture evidence as very low to low certainty.

Measura does not scan bones. If you are older and worry about falling, the more useful measurement is of steadiness itself. Vestibular and balance testing records how well you hold your balance, a fall-risk finding worth having for its own sake rather than as a fear borrowed from a pill. More is in dizziness, balance and falls.

What to bring to your next appointment

• The date the prescription started and the reason written down that day.
• Every attempt to stop: which day the symptoms returned and how long they lasted.
• Whether reflux was ever confirmed with a test, rather than inferred from a response to the pill.
• Whether H. pylori, B12 and minerals have been checked, and whether body composition should be measured.

More prompts are in questions worth asking your doctor. The studies behind these figures are in the companion deep dive for The Angry Gut. Physicians can read the screening version for practices, and a pain prescription that stalls the gut even more completely comes next.

Frequently asked questions

Is long-term PPI use safe?

With a clear, current indication, the randomized evidence is reassuring: three years of pantoprazole in 17,598 people raised enteric infection slightly and nothing else that was measured. The real costs are absorption, especially B12, and a rebound that makes stopping hard. Whether your original reason still applies is a question for your prescriber. Read about understanding your results.

Does low stomach acid cause acid reflux?

No. When heartburn patients had their acid nearly eliminated for a week, the number of reflux events did not fall; only the acid content changed. Reflux is driven by pressure on the valve and by where the pool of acid sits after a meal, particularly with a hiatal hernia. See why body composition is not the same as weight.

Why does my heartburn come back worse when I stop my PPI?

Weeks of acid suppression raise gastrin and expand the acid-making cells, so stopping releases more acid than before. In healthy volunteers with no reflux, 44% had acid symptoms after stopping, against 15% on placebo. The flare usually starts within the first two weeks and then settles. Plan any change with your physician rather than stopping on your own. Bring these questions to your doctor.

Can Measura test my stomach acid?

No. Gastric pH and acid studies, impedance monitoring, endoscopy and H. pylori testing are gastroenterology tests done elsewhere. Measura measures the wider picture instead, including laboratory panels, body composition and balance, with results sent to your physician for interpretation. See what Measura actually measures.

Should my B12 be checked if I take omeprazole?

It is a reasonable question to raise. Two or more years on a proton pump inhibitor carried an odds ratio of 1.65 for B12 deficiency, and 1.95 above 1.5 pills a day. A blood test is the only way to know where you stand, and your physician decides what the panel includes and what a result means. Learn about laboratory panels.

What happens if you take a PPI for a long time?

Mostly, absorption changes. Two or more years on a proton pump inhibitor carried 1.65 times the odds of vitamin B12 deficiency, and minerals point the same way. Pepsin needs acid, so protein reaches the small intestine less broken down. Stopping brings a rebound: 44% of healthy volunteers had acid symptoms after eight weeks on the pill, against 15% on placebo. Laboratory panels show where your own numbers stand.

Can you take omeprazole for 20 years?

Some people genuinely need acid suppression for years: after a bleeding ulcer, with erosive esophagitis or Barrett’s esophagus, or while taking an anti-inflammatory every day. Many others stay on a short course that nobody ended. Whether the pill still has a job is a decision for the physician who prescribed it, never a reason to stop on your own, and years on it are the history that makes B12 and mineral testing worth raising.

Is there a safer alternative to PPIs?

For the reflux itself, the lifestyle measures that held up in a systematic review were weight loss and raising the head of the bed, and both work by lowering pressure on the valve. Body composition testing shows whether weight lost is fat rather than muscle. Any change to the medicine is a decision to make with your prescriber, planned around the rebound that follows stopping.

References

• Vela, M. F., Camacho-Lobato, L., Srinivasan, R., Tutuian, R., Katz, P. O., & Castell, D. O. (2001). Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology, 120(7), 1599-606. https://doi.org/10.1053/gast.2001.24840
• Wu, J. C. Y., Mui, L. M., Cheung, C. M. Y., Chan, Y., & Sung, J. J. Y. (2006). Obesity is associated with increased transient lower esophageal sphincter relaxation. Gastroenterology, 132(3), 883-9. https://doi.org/10.1053/j.gastro.2006.12.032
• Reimer, C., Søndergaard, B., Hilsted, L., & Bytzer, P. (2009). Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy. Gastroenterology, 137(1), 80-87, 87.e1. https://doi.org/10.1053/j.gastro.2009.03.058
• Namikawa, K., & Björnsson, E. S. (2024). Rebound acid hypersecretion after withdrawal of long-term proton pump inhibitor (PPI) treatment: Are PPIs addictive?. International Journal of Molecular Sciences, 25(10), 5459. https://doi.org/10.3390/ijms25105459
• Hurwitz, A., Brady, D. A., Schaal, S. E., Samloff, I. M., Dedon, J., & Ruhl, C. E. (1997). Gastric acidity in older adults. JAMA, 278(8), 659-62. https://pubmed.ncbi.nlm.nih.gov/9272898/
• Lam, J. R., Schneider, J. L., Zhao, W., & Corley, D. A. (2013). Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA, 310(22), 2435-42. https://doi.org/10.1001/jama.2013.280490
• Mohammadi, K., Yaribash, S., Razi, B., & Dashti-Khavidaki, S. (2021). Comparing safety of proton-pump inhibitors versus H2-receptor antagonists in kidney transplant recipients: A systematic review and meta-analysis. Journal of clinical pharmacy and therapeutics, 47(5), 567-574. https://doi.org/10.1111/jcpt.13589
• Kaltenbach, T., Crockett, S., & Gerson, L. B. (2006). Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach. Archives of Internal Medicine, 166(9), 965-971. https://doi.org/10.1001/archinte.166.9.965
• Moayyedi, P., Eikelboom, J. W., Bosch, J., Connolly, S. J., Dyal, L., Shestakovska, O., Leong, D., Anand, S. S., Stork, S., Branch, K. R. H., Bhatt, D. L., Verhamme, P. B., O’Donnell, M., Maggioni, A. P., Lonn, E. M., Piegas, L. S., Ertl, G., Keltai, M., Bruns, N. C., … Yusuf, S. (2019). Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin. Gastroenterology, 157(3), 682-691.e2. https://doi.org/10.1053/j.gastro.2019.05.056

Related reading

• Visceral Fat vs Subcutaneous Fat: What Testing Can Show
• Narcotic Bowel Syndrome: What Testing Can and Cannot Show
• Laboratory Panels

Medically reviewed by Dr. Gurpreet Singh Padda, MD, MBA, MHP, medical director of Measura. Last reviewed September 12, 2026.